Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Aschele

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracilC Aschele, D Debernardis, R Bandelloni, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 29, 2006
Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancerE Urso, S Serpentini, S Pucciarelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancerA F Sobrero, C Aschele, A P Guglielmi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2005
A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancerC Aschele, M L Friso, S Pucciarelli, et al.
British Journal of Cancer|February 14, 1998
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II studyC Aschele, A Guglielmi, G L Frassineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combinationS Cascinu, V Catalano, C Aschele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)C Pinto, F Di Fabio, E Maiello, et al.
British Journal of Cancer|April 20, 2001
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancerA Sobrero, A Guglielmi, M Cirillo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinomaD I Jodrell, T R J Evans, W Steward, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 2, 2025
Geriatric Oncology in Italy. Where we are. A CIPOMO (Italian College of Primary Hospital Medical Oncologists)-Gioger (Italian Group of Geriatric Oncology) SurveyS Barni, A Luciani, P Tralongo, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracilC Aschele, D Debernardis, R Bandelloni, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 29, 2006
Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancerE Urso, S Serpentini, S Pucciarelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 1995
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancerA F Sobrero, C Aschele, A P Guglielmi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2005
A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancerC Aschele, M L Friso, S Pucciarelli, et al.
British Journal of Cancer|February 14, 1998
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II studyC Aschele, A Guglielmi, G L Frassineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combinationS Cascinu, V Catalano, C Aschele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)C Pinto, F Di Fabio, E Maiello, et al.
British Journal of Cancer|April 20, 2001
5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancerA Sobrero, A Guglielmi, M Cirillo, et al.
European Journal of Cancer (Oxford, England : 1990)|August 4, 2004
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinomaD I Jodrell, T R J Evans, W Steward, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 2, 2025
Geriatric Oncology in Italy. Where we are. A CIPOMO (Italian College of Primary Hospital Medical Oncologists)-Gioger (Italian Group of Geriatric Oncology) SurveyS Barni, A Luciani, P Tralongo, et al.
Pageof 4